To believe that the US and its allies can just continue to go around the world, in country after country, and bomb and kill innocent people - Muslims - and not be targeted with “terrorist” attacks is, for obvious reasons, lunacy. As Bradford University professor Paul Rogers told Jones, the bombing of Mali “will be portrayed as ‘one more example of an assault on Islam’”. Whatever hopes that may exist for an end to the “war on terror” are systematically destroyed by ongoing aggression.
The French bombing of Mali, perhaps to include some form of US participation, illustrates every lesson of western intervention. The “war on terror” is a self-perpetuating war precisely because it endlessly engenders its own enemies and provides the fuel to ensure that the fire rages without end. But the sloganeering propaganda used to justify this is so cheap and easy - we must kill the Terrorists! - that it’s hard to see what will finally cause this to end. The blinding fear - not just of violence, but of Otherness - that has been successfully implanted in the minds of many western citizens is such that this single, empty word (Terrorists), standing alone, is sufficient to generate unquestioning support for whatever their governments do in its name, no matter how secret or unaccompanied by evidence it may be."
Monsanto’s earnings nearly doubled analysts’ projections and its total revenue reached $2.94bn at the end of 2012. The increased price of Roundup herbicide, continued market domination in the United States and, perhaps most significant, expanded markets in Latin America are all contributing factors to Monsanto’s booming business.
Exploiting their patent on transgenic corn, soybean and cotton, Monsanto asserts an insidious control of those agricultural industries in the US, effectively squeezing out conventional farmers (those using non-transgenic seeds) and eliminating their capacity to viably participate and compete on the market. (Until the end of 2012, Monsanto was under investigation by the Department of Justice for violating anti-trust laws by practicing anticompetitive activities towards other biotech companies, but that investigation was quietly closed before the year’s end.)
The seemingly modest objective of the current lawsuit, OSGATA et al v Monsanto, originally filed in March 2011, is to acquire legal protection for organic and conventional farmers from Monsanto’s aggressive prosecution of inadvertent patent infringements. But the implications of the suit are momentous. If the DC Court of Appeal reverses the dismissal, a process of discovery will be instigated that could unveil a reservoir of information, access to which Monsanto has withheld from public knowledge - both by not disclosing it and preventing independent research."